Welcome to our dedicated page for Sociedad Quimica y Minera SEC filings (Ticker: SQM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Sociedad Química y Minera de Chile S.A. (SQM) provides access to the company’s regulatory reports as a foreign private issuer. SQM files annual reports on Form 20-F and interim reports on Form 6-K under the Securities Exchange Act of 1934, presenting consolidated financial statements, segment information and descriptions of its operations in lithium and derivatives, Specialty Plant Nutrition, iodine and derivatives, potassium and other businesses.
Through its Form 6-K submissions, SQM furnishes earnings releases for periods such as the three, six, nine and twelve months ended on various dates, along with translated consolidated interim financial statements. These documents detail revenues, net income or loss, gross profit, and segment performance, as well as notes on accounting policies, joint ventures, related-party transactions and risk management. They also include disclosures on capital expenditure plans, bond issuances in the Chilean market and the financial effects of partnerships such as the association with Codelco for the Salar de Atacama.
Some 6-K filings address specific corporate events, including the completion of the association agreement with Codelco, approval by the State Administration for Market Regulation of the People’s Republic of China, and the issuance of local hybrid bonds. Others provide unaudited interim financial statements and reconciliations that clarify tax treatment and other accounting matters.
On Stock Titan, these filings are paired with AI-powered summaries that highlight key figures, segment trends and notable disclosures from each document. Users can quickly see how SQM reports lithium volumes and pricing, iodine and plant nutrition performance, capital structure changes and the impact of joint ventures, while still having direct access to the full text of each Form 20-F and Form 6-K filed with the SEC.
Sociedad Qu edmica y Minera de Chile S.A. (SQM) presents consolidated interim financial statements for the six months ended June 30, 2025 and comparative periods. Total assets were ThUS$11,524,036 with total equity of ThUS$5,393,685 and total liabilities of ThUS$6,130,351. For January to June 2025 revenue was ThUS$2,079,307 and gross profit ThUS$558,264. SQM reported net income of ThUS$227,720 for the period, a reversal from a net loss of ThUS$653,860 in the prior-year period, driven after income tax expense of ThUS$130,958 in 2025 versus a large tax expense in 2024. Cash and cash equivalents were ThUS$1,565,586 at June 30, 2025 and current inventories were ThUS$1,851,147. The Joint Venture Agreement with Codelco is disclosed but not effective as of the reporting date and, if conditions are met in 2025, would reclassify certain amounts to non-controlling interests and create a dividend payable to Codelco calculated by an agreed methodology.
Sociedad Quimica y Minera de Chile S.A. (SQM) reports select metrics for mid-2025. The company indicated it files annual reports on Form 20-F and provided an address for its principal executive office in Santiago, Chile. The Lithium and Derivatives segment reported an adjusted gross margin of 21% for Q2 2025. In Specialty Plant Nutrition (SPN), revenue for the six months ended June 30, 2025 was US$472.6 million, slightly above US$468.2 million for the same period in 2024. SPN revenue for Q2 2025 was US$260.3 million, essentially flat versus US$260.5 million in Q2 2024.